Nanoemulsified orlistat-embedded multi-unit pellet system (MUPS) with improved dissolution and pancreatic lipase inhibition

References

• Blackburn GL, Wollner S, Heymsfield SB. Lifestyle interventions for the treatment of class III obesity: a primary target for nutrition medicine in the obesity epidemic. Am J Clin Nutr 2010;91:289–92
   Google Scholar
• McAllister EJ, Dhurandhar NV, Keith SW, et al. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr 2009;49:868–913
   PubMed Web of Science ®Google Scholar
• Mauro M, Taylor V, Wharton S, Sharma AM. Barriers to obesity treatment. Eur J Int Med 2008;19:173–80
   PubMed Web of Science ®Google Scholar
• Correia MLG, Haynes WG. Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Dr 2005;10:643–60
   PubMedGoogle Scholar
• Ballinger A. Orlistat in the treatment of obesity. Exp Opin Pharmcother 2000;1:841–7
   PubMedGoogle Scholar
• McClendon KS, Riche DM, Uwaifo GI. Orlistat: current status in clinical therapeutics. Expert Opin Drug Saf 2009;8:727–44
   PubMed Web of Science ®Google Scholar
• Dolenc A, Govedarica B, Dreu R, et al. Nanosized particles of orlistat with enhanced in vitro dissolution rate and lipase inhibition. Int J Pharm 2010;396:149–55
   PubMed Web of Science ®Google Scholar
• Cavaliere H, Floriano I, Medeiros NG. Gastrointestinal side effects of orlistat may be prevented by concomitant prescription of natural fibers (psyllium mucilloid). Int J Obes Relat Metab Disord 2001;7:1095–9
   Google Scholar
• Bray GA, Greenway FL. Current and potential drugs for treatment of obesity. Endocr Rev 1999;20:805–75
   PubMed Web of Science ®Google Scholar
• Shah N, Zeller M. Tetrahydrolipstatin containing formulations. US 98/6004996. Hoffman-LaRoche AG; 1998
   Google Scholar
• Myers GL, Hilbert SD, Boone BJ. Film delivery system for tetrahydrolipstatin. US2009/0104270. Hoffmann&Baron, LLP; 2009
   Google Scholar
• Liversidge GG, Jenkins S. Nanoparticulate lipase inhibitor compositions, US 2006/0246141 A1. Elan Drug Delivery Inc; 2006
   Google Scholar
• Ko J, Small DM. Behaviour of tetrahydrolipstatin in biological model membranes and emulsions. J Lipid Res 1997;38:1544–52
   PubMedGoogle Scholar
• Tiss A, Lengsfeld H, Hadvary P, et al. Transfer of orlistat through oil-water interfaces. Chem Phys Lipids 2002;119:41–9
   PubMedGoogle Scholar
• Shah P, Bhalodia D, Shelat P. Nanoemulsion: a pharmaceutical review. Syst Rev Pharm 2010;1:24–32
   Google Scholar
• Zhao Y, Wang C, Chow AH, et al. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: Formulation and bioavailability studies. Int J Pharm 2010;383:170–7
   PubMed Web of Science ®Google Scholar
• Lovelyn, C. Current state of nanoemulsions in drug delivery. J Biomat Nanobiotechnol 2011;2:626–39
   Google Scholar
• Siah YT, Manickam S, Angela MHN, Parthasarathy S. Anti-inflammatory and analgesic activity of novel oral aspirin-loaded nanoemulsion and nano multiple emulsion formulations generated using ultrasound cavitation. Int J Pharm 2012;430:299–306
   PubMedGoogle Scholar
• Siah YT, Manickam S, Tan KW, Nashiru B. Formulation development and optimization of a novel cremophore el-based nanoemulsion using ultrasound cavitation. Ultrason Sonochem 2012;19:330–45
   PubMedGoogle Scholar
• Muller RH, Harden D, Keck CM. Development of industrially feasible concentrated 30% and 40% nanoemulsions for intravenous drug delivery. Drug Dev Ind Pharm 2012;38:420–30
   PubMed Web of Science ®Google Scholar
• Dragovic RA, Gardiner C, Brooks AS, et al. Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomedicine 2011;7:780–8
   PubMed Web of Science ®Google Scholar
• Boyd RD, Pichaimuthu SK, Cuenat A. New approach to inter-technique comparisons for nanoparticle size measurements; using atomic force microscopy, nanoparticle tracking analysis and dynamic light scattering. Colloid Surface Physicochem Eng Aspects 2011;387:35–42
   Google Scholar
• Carriere F, Renou C, Ransac S, et al. Inhibition of gastrointestinal lipolysis by orlistat during digestion of test meals in healthy volunteers. Am J Physiol Gastrointest Liver Physiol 2001;281:G16–28
   PubMed Web of Science ®Google Scholar
• Sternby B, Hartmann D, Borgstroom B, Nilsson P. Degree of in vivo inhibition of human gastric and pancreatic lipases by orlistat (tetrahydrolipstatin, THL) in the stomach and small intestine. Clin Nutr 2002;21:395–402
   PubMed Web of Science ®Google Scholar
• Lee YP, Chung GH, Rhee JS. Purification and characterization of Pseudomonas fluorescens SIK W1 lipase expressed in Escherichia coli. Biochim Biophys Acta 1993;1169:156–64
   PubMed Web of Science ®Google Scholar
• Bustanji Y, Al-masri IM, Mohammad M, et al. Pancreatic lipase inhibition activity of trilactone terpenes of Ginkgo biloba. J Enzyme Inhib Med Chem 2011;26:453–9
   PubMed Web of Science ®Google Scholar
• Mohammad M, Aiedeh KM, Alkhatib HS, et al. Comparative enzymatic inhibition assay as a surrogate indicator of pharmaceutical and potency equivalence of two orlistat formulations. Jordan J Pharm Sci 2010;3:69–75
   Google Scholar
• Huyskens PL, Haulaitpirson MC. A new expression for the combinatorial entropy of mixing in liquid-mixtures. J Mol Liq 1985;31:135–51
   Web of Science ®Google Scholar
• Ahmed K, Li Y, McClements DJ, Xiao H. Nanoemulsion and emulsion-based delivery systems for curcumin: encapsulation and release properties. Food Chem 2012;132:799–807
   Web of Science ®Google Scholar
• Qian C, McClements DJ. Formation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: Factors affecting particle size. Food Hydrocolloid 2011;25:1000–8
   Web of Science ®Google Scholar
• Siah YT, Shridharan P, Manickam S. Impact of process parameters in the generation of novel aspirin nanoemulsions comparative studies between ultrasound cavitation and microfluidiser. Ultrason Sonochem 2013;20:485–97
   PubMedGoogle Scholar
• Jafari SM, Assadpoor E, He YH, Bhandari B. Re-coalescence of emulsion droplets during high-energy emulsification. Food Hydrocolloid 2008;22:1191–202
   Web of Science ®Google Scholar
• Tcholakova S, Denkov ND, Sidzhakova D, et al. Interrelation between drop size and protein adsorption at various emulsification conditions. Langmuir 2003;19:5640–9
   Web of Science ®Google Scholar
• Lovelyn C. Current state of nanoemulsions in drug delivery. J Biomat Nanobiotechnol 2011;2:626–39
   Google Scholar
• Batista AP, Raymundo A, Sousa I, Empis J. Rheological characterization of coloured oil-in-water food emulsions with lutein and phycocyanin added to the oil and aqueous phases. Food Hydrocolloid 2006;20:44–52
   Web of Science ®Google Scholar
• Tcholakova S, Lesov I, Golemanov K, et al. Efficient emulsification of viscous oils at high drop volume fraction. Langmuir 2011;27:14783–96
   PubMed Web of Science ®Google Scholar
• Chawla G, Gupta P, Thilagavathi R. Characterization of solid-state forms of celecoxib. Eur J Pharm Sci 2003;20:305–17
   PubMed Web of Science ®Google Scholar
• Simon B, George Z, David E, et al. Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns. Pharm Res 2006;23:2333-49
   PubMedGoogle Scholar
• Hancock BC, Carlson GT, Ladipo DD, et al. Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance. Int J Pharm 2002;24:73–85
   Google Scholar
• Choi S-J, Hwang JM, Kim SI. A colorimetric microplate assay method for high throughput analysis of lipase activity. J Biochem Mol Biol 2003;36:417–20
   PubMedGoogle Scholar
• Ani A, Ani M, Moshtaghie AA, Ahmadvand H. Effect of titanium on lipoprotein lipase activity in vivo and in vitro. J Trace Elem Med Biol 2010;24:95–8
   PubMedGoogle Scholar
• Tiss A, Lengsfeld H, Carriere F, et al. Enzymatic inhibition of human pancreatic lipase by tetrahydrolipstatin: Further kinetic studies showing its reversibility. J Mol Catal B: Enzyme 2009;58:41–7
   Web of Science ®Google Scholar